Link N Peptide Fragments Stimulate Cartilage Matrix Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cartilage and intervertebral disc disorders, such as osteoarthritis and degenerative disc disease, lack effective methods for repairing or reversing cartilage and disc degeneration, relying on surgical interventions that can lead to biomechanical changes and adjacent-level disc degeneration, with no therapies capable of reversing cartilage degradation.
Innovation Solution
The use of Link N fragments, specifically peptides like DHLSDNYT and DHHSDNYT, to induce proteoglycan and collagen synthesis in cartilage and disc cells, promoting matrix repair and potentially treating disorders like arthritis and intervertebral disc degeneration by enhancing extracellular matrix production and reducing inflammatory cytokine activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If surgical excision, cage insertion, or vertebral bone fusion is performed to treat IVD degeneration, then pain relief is achieved in the short term, but spine biomechanics are altered leading to adjacent-level disc degeneration
Solution Approach 1:
The invention segments the full-length link protein into smaller functional fragments (such as N-terminal fragments containing the first 16 amino acids) that retain the ability to stimulate proteoglycan synthesis. This segmentation allows the therapeutic effect to be achieved with a smaller, more manageable peptide that can be administered systemically without the complications of larger protein therapy, while still providing the benefit of biological repair to prevent adjacent-level degeneration.
Solution Approach 2:
The link protein fragment acts as an intermediary substance that mediates between the administered therapy and the degenerating disc tissue. It stimulates endogenous proteoglycan synthesis by disc cells, serving as a biological mediator that promotes tissue repair and maintains spine biomechanics, thereby preventing adjacent-level disc degeneration while providing pain relief.
2Reliability
If growth factors such as TGF-β and BMP 7 are used to promote ECM production and downregulate proteinase activity, then cartilage and disc repair is enhanced, but cost increases and potential side effects arise
Solution Approach 1:
The invention uses a short-lived peptide fragment (16 amino acids) instead of expensive, complex growth factors. This small peptide can be synthesized cost-effectively and administered as a temporary therapy that stimulates endogenous repair mechanisms. The fragment's short half-life reduces the risk of long-term side effects while still providing the necessary stimulus for proteoglycan synthesis and tissue repair.
Solution Approach 2:
The invention changes the molecular parameters from large, complex growth factors (TGF-β, BMP 7) to a small peptide fragment with 16 amino acids. This parameter change dramatically reduces cost and potential side effects while maintaining the therapeutic function of stimulating proteoglycan synthesis and promoting cartilage and disc repair through activation of specific signaling pathways.
3Reliability
If proteases are inhibited to prevent ECM degradation, then structural failure and loss of IVD height are reduced, but normal tissue remodeling processes are also impaired
Solution Approach 1:
The invention converts the harmful effect of proteases (which cause ECM degradation) into a beneficial process by stimulating proteoglycan synthesis. The link protein fragment activates disc cells to produce new proteoglycans that replace degraded ECM components. This approach maintains the natural proteolytic remodeling process while simultaneously enhancing tissue repair through increased proteoglycan production, thereby preserving both structural integrity and normal tissue remodeling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Link N fragments stimulate proteoglycan and collagen synthesis in both healthy and degenerative conditions, including inflammatory environments, effectively increasing matrix production and potentially alleviating symptoms of cartilage and disc disorders, offering a biological repair approach to existing surgical-centric treatments.
Implementation Method 1
Link N fragments stimulate proteoglycan and collagen synthesis in both healthy and degenerative conditions
Implementation Method 2
Link N fragments stimulate proteoglycan and collagen synthesis in both healthy and degenerative conditions
Implementation Method 3
enhancing extracellular matrix production and reducing inflammatory cytokine activity
Data Source
Figure 1a~1b
Figure 2~3b
Figure 4a~4c
AI summary
An isolated polypeptide comprising a peptide selected from: i) DHX1SDNYT, wherein X1 is L or H (SEQ ID NO:3); ii) a conservative variant of i) iii) a fragment of i) or ii); wherein the conservative variant and/or fragment retains biological activity and the peptide is 15 or less amino acids as well as recombinant cells, and uses thereof.